Perylenequinone derivatives and uses thereof
AssigneeQuest Pharmatech Inc.
InventorsSanjay K. Sharma, Thomas Woo, Selvaraj Naicker
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds which are perylenequinone derivatives, their stereoisomers and atropisomers. These compounds can be particularly useful as photosensitizers or sononsensitizers in photodynamic or sonodynamic therapy. The invention also relates to various methods for using these compounds in photodynamic and/or sonodynamic therapy. The compounds also are useful as therapeutic agents for treating various hyperproliferative disorders.
Claims9
A compound of formula (IIIa) or (IIIb) or stereoisomer or atropisomer thereof:
- wherein
- T is a —CH2—;
- R4 and R5 are independently hydrogen, deuterium, hydroxy, oxygen, halogen, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C3-C8 cycloalkyl, C4-C10 cycloalkenyl, C6-C12 aryl, C6-C12 aralkyl, C1-C12 heterocyclyl, C1-C12 heteroaryl, —COR1, —(CH2)mOR1, —CO2H, —CO2R1, —C(O)N(R1)2, —C(O)NH(R1), —C(O)NH2 or an amino suitable protecting group,
- said C1-C4 alkylenyl, C2-C4 alkenylenyl, C1-C4 heteroalkylenyl, C2-C4 heteroalkenylenyl, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl C3-C8 cycloalkyl, C4-C10 cycloalkenyl, C6-C12 aryl, C6-C12 aralkyl, C1-C12 heterocyclyl, and C1-C12 heteroaryl being unsubstituted or substituted with at least one substituent selected from the group consisting of a halogen atom, hydroxy, carboxy, thiol, azide, nitro, C1-C8 deuterated alkyl group comprising at least one deuterated atom, —COH, —COR1, —(CH2)mOR1, —CO2H, —CO2R1, —C(O)N(R1)2, —C(O)NH(R1), —C(O)NH2, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C3-C8 cycloalkyl, C4-C10 cycloalkenyl, C6-C12 aryl, C6-C12 aralkyl, C1-C12 heterocyclyl and C1-C12 heteroaryl;
- R1 is a hydrogen atom, C1-C8 alkyl, C3-C8 cycloalkyl, C4-C10 cycloalkenyl, C6-C12 aralkyl, or C1-C12 heterocyclyl;
- each R2 is independently a hydrogen atom, C1-C8 alkyl, C3-C8 cycloalkyl, C4-C10 cycloalkenyl, C6-C12 aralkyl, or C1-C12 heterocyclyl;
- p has a value of 4 so that ring A is a six-membered ring;
- R6 is hydrogen;
- and
- R7 is hydrogen;
- m is an integer having a value of 1 to 13,
- or a pharmaceutically acceptable salt thereof.
A process for preparing a compound of formula IIIa or IIIb or stereoisomer or atropisomer thereof:
- wherein
- T is a —CH2—;
- R4 and R5 are independently hydrogen, deuterium, hydroxy, oxygen, halogen, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C3-C8 cycloalkyl, C4-C10 cycloalkenyl, C6-C12 aryl, C6-C12 aralkyl, C1-C12 heterocyclyl, C1-C12 heteroaryl, —COR1, —(CH2)mOR1, —CO2H, —CO2R1, —C(O)N(R1)2, —C(O)NH(R1), —C(O)NH2 or an amino suitable protecting group,
- said C1-C4 alkylenyl, C2-C4 alkenylenyl, C1-C4 heteroalkylenyl, C2-C4 heteroalkenylenyl, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl C3-C8 cycloalkyl, C4-C10 cycloalkenyl, C6-C12 aryl, C6-C12 aralkyl, C1-C12 heterocyclyl, and C1-C12 heteroaryl being unsubstituted or substituted with at least one substituent selected from the group consisting of a halogen atom, hydroxy, carboxy, thiol, azide, nitro, C1-C8 deuterated alkyl group comprising at least one deuterated atom, —COH, —COR1, —(CH2)mOR1, —CO2H, —CO2R1, —C(O)N(R1)2, —C(O)NH(R1), —C(O)NH2, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C3-C8 cycloalkyl, C4-C10 cycloalkenyl, C6-C12 aryl, C6-C12 aralkyl, C1-C12 heterocyclyl and C1-C12 heteroaryl;
- R1 is a hydrogen atom, C1-C8 alkyl, C3-C8 cycloalkyl, C4-C10 cycloalkenyl, C6-C12 aralkyl, or C1-C12 heterocyclyl;
- each R2 is independently a hydrogen atom, C1-C8 alkyl, C3-C8 cycloalkyl, C4-C10 cycloalkenyl, C6-C12 aralkyl, or C1-C12 heterocyclyl;
- p has a value of 4 so that ring A is a six-membered ring;
- R6 is hydrogen;
- and
- R7 is hydrogen;
- said process comprising:
- a) reacting a compound of formula (IVa) or (IVb):
- wherein
- R2 is as previously defined,
- with a compound of formula (VI):
- wherein
- T, R4, R5, and p are as previously defined,
- wherein compounds of formula (IVa) and (IVb) when reacted with compound (VI) result in compound (IIIa) and (IIIb), respectively.
A process for preparing a mixture of the compound of formula IIIa and IIIb or a stereoisomer or atropisomer thereof:
- wherein
- T is a —CH2;
- R4 and R5 are independently hydrogen, deuterium, hydroxy, oxygen, halogen, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C3-C8 cycloalkyl, C4-C10 cycloalkenyl, C6-C12 aryl, C6-C12 aralkyl, C1-C12 heterocyclyl, C1-C12 heteroaryl, —COR1, —(CH2)mOR1, —CO2H, —CO2R1, —C(O)N(R1)2, —C(O)NH(R1), —C(O)NH2 or an amino suitable protecting group,
- said C1-C4 alkylenyl, C2-C4 alkenylenyl, C1-C4 heteroalkylenyl, C2-C4 heteroalkenylenyl, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl C3-C8 cycloalkyl, C4-C10 cycloalkenyl, C6-C12 aryl, C6-C12 aralkyl, C1-C12 heterocyclyl, and C1-C12 heteroaryl being unsubstituted or substituted with at least one substituent selected from the group consisting of a halogen atom, hydroxy, carboxy, thiol, azide, nitro, C1-C8 deuterated alkyl group comprising at least one deuterated atom, —COH, —COR1, —(CH2)mOR1, —CO2H, —CO2R1, —C(O)N(R1)2, —C(O)NH(R1), —C(O)NH2, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C3-C8 cycloalkyl, C4-C10 cycloalkenyl, C6-C12 aryl, C6-C12 aralkyl, C1-C12 heterocyclyl and C1-C12 heteroaryl;
- R1 is a hydrogen atom, C1-C8 alkyl, C3-C8 cycloalkyl, C4-C10 cycloalkenyl, C6-C12 aralkyl, or C1-C12 heterocyclyl;
- each R2 is independently a hydrogen atom, C1-C8 alkyl, C3-C8 cycloalkyl, C4-C10 cycloalkenyl, C6-C12 aralkyl, or C1-C12 heterocyclyl;
- p has a value of 4 so that ring A is a six-membered ring;
- R6 is hydrogen;
- and
- R7 is hydrogen;
- said process comprising:
- a) reacting a compound of formula (IVa) and (IVb):
- wherein
- R2 is as previously defined, with a compound of formula (VI):
- wherein
- T, R4, R5, and p are as previously defined.
Dependencies are inferred from the claim text.